Showing results (81-90 of 216) with videos related to
Sort By:
Pageof 22
Harm Reduction Journal|July 25, 2024
Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative studyErin Bredenberg, Catherine Callister, Ashley Dafoe, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling StudyJoshua A Barocas, Golnaz Eftekhari Yazdi, Alexandra Savinkina, et al.Journal of Hospital Medicine|June 12, 2025
Starting hepatitis C treatment during acute care hospitalizations: A qualitative study of barriers and facilitatorsErin Bredenberg, Catherine Callister, Ashley Dafoe, et al.The International Journal on Drug Policy|November 20, 2019
A review of network simulation models of hepatitis C virus and HIV among people who inject drugsMeghan Bellerose, Lin Zhu, Liesl M Hagan, et al.Journal of General Internal Medicine|March 6, 2020
HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid EpidemicSabrina A Assoumou, Jianing Wang, Shayla Nolen, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|April 3, 2020
Feasibility Study of a Quasi-experimental Regional Opioid Safety Prescribing Program in Veterans Health Administration Emergency DepartmentsNathalie Dieujuste, Rachel Johnson-Koenke, Melissa Christopher, et al.AIDS (London, England)|September 21, 2018
Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United StatesAshley A Leech, James F Burgess, Meg Sullivan, et al.Obstetrics and Gynecology|January 12, 2019
Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal CareAbriana Tasillo, Golnaz Eftekhari Yazdi, Shayla Nolen, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2017
Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit AnalysisJ Morgan Freiman, Karen R Jacobson, Winnie R Muyindike, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 15, 2025
Modeling Recurrent Events: A Tutorial Based on Relapse and Remitting Episodes during Medication-Assisted Treatment for Opioid Use DisorderStavroula A Chrysanthopoulou, Jianing Wang, Shayla Nolen, et al.Pageof 22